Drugs / phentermine/topiramate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04531176 | Sep 2020 → Aug 2022 | obesity disorder, type 2 diabetes mellitus | The Cleveland Clinic | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | phentermine/topiramate | “2) phentermine/topiramate extended-release” NCT04531176 ↗ |
| Route | Oral | “Phentermine / Topiramate Extended Release Oral Capsule” NCT04531176 ↗ |